Ngā hua rapu - Michael S. Rabin
- E whakaatu ana i te 1 - 17 hua o te 17
-
1
Experience facilitates olfactory quality discrimination mā Michael D. Rabin
I whakaputaina 1988Artigo -
2
Determinants of measured olfactory sensitivity mā Michael D. Rabin, William S. Cain
I whakaputaina 1986Artigo -
3
-
4
Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. mā Stanley R. Riddell, Michael S. Rabin, Adam P. Geballe, William J. Britt, P D Greenberg
I whakaputaina 1991Artigo -
5
-
6
Development of Central Nervous System Metastases in Patients with Advanced Non–Small Cell Lung Cancer and Somatic <i>EGFR</i> Mutations Treated with Gefitinib or Erlotinib mā Stéphanie Héon, Beow Y. Yeap, Gregory Joseph Britt, Daniel B. Costa, Michael S. Rabin, David M. Jackman, Bruce E. Johnson
I whakaputaina 2010Artigo -
7
Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab mā Mizuki Nishinoa, Sarah K. Cryer, Yuka Okajim, Lynette M. Sholl, Hiroto Hatabu, Michael S. Rabin, David M. Jackman, Bruce E. Johnson
I whakaputaina 2012Artigo -
8
Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non–Small-Cell Lung Cancer Patients Treated with EGFR TKI mā Mizuki Nishino, Suzanne E. Dahlberg, Stephanie Cardarella, David M. Jackman, Michael S. Rabin, Hiroto Hatabu, Pasi A. Jänne, Bruce E. Johnson
I whakaputaina 2013Artigo -
9
Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival mā Mizuki Nishino, Stephanie Cardarella, Suzanne E. Dahlberg, Tetsuro Araki, Christine Lydon, David M. Jackman, Michael S. Rabin, Hiroto Hatabu, Bruce E. Johnson
I whakaputaina 2015Artigo -
10
Association between Smoking History and Tumor Mutation Burden in Advanced Non–Small Cell Lung Cancer mā Xinan Wang, Biagio Ricciuti, Tom Nguyen, Xihao Li, Michael S. Rabin, Mark M. Awad, Xihong Lin, Bruce E. Johnson, David C. Christiani
I whakaputaina 2021Artigo -
11
Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors mā Mizuki Nishino, Stephanie Cardarella, Suzanne E. Dahlberg, David M. Jackman, Nikhil H. Ramaiya, Hiroto Hatabu, Michael S. Rabin, Pasi A. Jnne, Bruce E. Johnson
I whakaputaina 2012Artigo -
12
The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with <i>EGFR</i> Mutations mā Stéphanie Héon, Beow Y. Yeap, Neal I. Lindeman, Victoria A. Joshi, Mohit Butaney, Gregory Joseph Britt, Daniel B. Costa, Michael S. Rabin, David M. Jackman, Bruce E. Johnson
I whakaputaina 2012Artigo -
13
Survival of Older Patients With Cancer in the Veterans Health Administration Versus Fee-for-Service Medicare mā Mary Beth Landrum, Nancy L. Keating, Elizabeth B. Lamont, Samuel R. Bozeman, Steven H. Krasnow, Lawrence N. Shulman, Jennifer R. Brown, Craig C. Earle, Michael S. Rabin, Barbara J. McNeil
I whakaputaina 2012Artigo -
14
A Phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer mā David M. Jackman, Leigh A. Cioffredi, L.J.A.M. Jacobs, Farhana Sharmeen, Linda K. Morse, Joan Lucca, Scott R. Plotkin, Paul Marcoux, Michael S. Rabin, Thomas J. Lynch, Bruce E. Johnson, Santosh Kesari
I whakaputaina 2015Artigo -
15
Feasibility of Using Algorithm-Based Clinical Decision Support for Symptom Assessment and Management in Lung Cancer mā Mary E. Cooley, Traci M. Blonquist, Paul J. Catalano, David F. Lobach, Barbara Halpenny, Ruth McCorkle, Ellis Johns, Ilana M. Braun, Michael S. Rabin, Fatma Zohra Mataoui, Kathleen Finn, Donna L. Berry, Janet L. Abrahm
I whakaputaina 2014Artigo -
16
Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib mā Geoffrey R. Oxnard, Yuebi Hu, Kathryn F. Mileham, Hatim Husain, Daniel B. Costa, Philip Tracy, Nora Feeney, Lynette M. Sholl, Suzanne E. Dahlberg, Amanda J. Redig, David J. Kwiatkowski, Michael S. Rabin, Cloud P. Paweletz, Kenneth S. Thress, Pasi A. Jänne
I whakaputaina 2018Artigo -
17
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets mā Priscilla K. Brastianos, Scott L. Carter, Sandro Santagata, Daniel P. Cahill, Amaro Taylor‐Weiner, Robert T. Jones, Eliezer M. Van Allen, Michael S. Lawrence, Peleg Horowitz, Kristian Cibulskis, Keith L. Ligon, Josep Tabernero, Joan Seoane, Elena Martínez‐Sáez, William T. Curry, Ian F. Dunn, Sun Ha Paek, Sung‐Hye Park, Aaron McKenna, Aaron Chevalier, Mara Rosenberg, Frederick G. Barker, Corey M. Gill, Paul Van Hummelen, Aaron R. Thorner, Bruce E. Johnson, Mai P. Hoang, Toni K. Choueiri, Sabina Signoretti, Carrie Sougnez, Michael S. Rabin, Nancy U. Lin, Eric P. Winer, Anat Stemmer‐Rachamimov, Matthew Meyerson, Levi A. Garraway, Stacey Gabriel, Eric S. Lander, Rameen Beroukhim, Tracy T. Batchelor, José Baselga, David N. Louis, Gad Getz, William C. Hahn
I whakaputaina 2015Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Oncology
Lung cancer
Cancer
Epidermal growth factor receptor
Gefitinib
Biology
Erlotinib
Genetics
Chemotherapy
Colorectal cancer
Gene
Pathology
Radiology
Audiology
Cancer research
Cognitive psychology
Communication
Economics
Engineering
KRAS
Lung
Neuroscience
Olfaction
Osimertinib
Psychology
Adenoid cystic carcinoma
Algorithm
Ambulatory